Since BPES is an inherited disease commonly caused by disease causal variants in FOXL2, genetic screening early in life is a good tool to predict the type of BPES and to provide genetic information for clinicians to make an informed decision regarding therapeutic approaches. Here, FOXL2 is linked to blepharophimosis, ptosis, and epicanthus inversus syndrome.